Milan summit on precision medicine

Integrative analyses to identify genetic determinants of immune responsiveness in cancer

Unknown primary and rare cancers

Estonian biobank, from basic research to public health

Lung cancer and precision medicine

Challenges of personalised oncology

Implementing precision medicine in cancer care

Clinical validity of NGS and innovation in clinical diagnosis

Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients

Latest in adjuvant therapy for renal cell carcinoma

Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer

Pseudo-invasive lesions of the breast